Developing and validating a prognostic disulfidptosis-related signature for glioblastoma: predicting radioresistance and synergestic effect with immunotherapy

Abstract Background Programmed cell death (PCD) modulated radioresistance is one of the predominant causes of treatment failure in glioblastoma (GBM). Disulfidptosis, a newly discovered form of PCD, plays a crucial role in GBM progression. However, the association among disulfidptosis, radiosensitiv...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Chen Chen, Peixin Tan, Wenqing Feng, Yuan Lei, Shushu Hu, Dehuan Xie, Yantan Liu, Chen Ren, Shasha Du
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Springer 2025-03-01
Schriftenreihe:	Journal of Cancer Research and Clinical Oncology
Schlagworte:	Disulfidptosis Tumor microenvironment Glioblastoma Radiotherapy Immunotherapy
Online-Zugang:	https://doi.org/10.1007/s00432-025-06159-0
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!